Dr. Goldlust is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4401 Wornall Road
Kansas City, MO 64111- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2009 - 2011
- NYU Grossman School of MedicineResidency, Neurology, 2006 - 2009
- Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 2005 - 2006
- Ohio State University College of MedicineClass of 2005
Certifications & Licensure
- MO State Medical License 2023 - 2025
- KS State Medical License 2023 - 2024
- NJ State Medical License 2011 - 2023
- NY State Medical License 2008 - 2011
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsEBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.Agrawal, P., David, K., Chen, Z., Sundaram, S., Kim, S., Vaca, R., Lin, Y., Singer, S., Malecek, M., Carter, J., Zayac, A., Kim, M., Reddy, N., Ney, D., Habib, A., Str...> ;Leukemia & Lymphoma. 2023 May 1
- 4 citationsTumor Treating Fields (TTFields) therapy vs physicians' choice standard-of-care treatment in patients with recurrent glioblastoma: a post-approval registry study (EF-19).Jay-Jiguang Zhu, Samuel A Goldlust, Lawrence R Kleinberg, Jérôme Honnorat, Nancy Ann Oberheim Bush, Zvi Ram> ;Discover. Oncology. 2022 Oct 14
- 10 citationsTetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding TrialSamuel Goldlust, Mojgan Kavoosi, Jennifer Nezzer, Mehran Kavoosi, Walter Korz, Kenneth Deck> ;Toxins. 2021 Mar 25
- Join now to see all
Press Mentions
- Investor Event Turns Spotlight on Novel Brain Cancer Drug Candidate Global Trial Under Way by CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)May 11th, 2022
- John Theurer Cancer Center Treats First Patient in U.S. With Investigational New Treatment for Brain CancerMarch 28th, 2022
- Hackensack University Medical Center Foundation Celebrates Formal Investiture of Samuel A. Goldlust, M.D.December 4th, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: